@Foumalin1 @VPrasadMDMPH What he did not say is increased mortality by 8% but who cares about that...right? https://t.co/gYYIenHfbY
@c_essene @VPrasadMDMPH Yup even same study they used for approval had 8% rel. mortality increase! https://t.co/gYYIenHfbY
@eppoeh Heb je daar een artikel van? Ik vond wel deze, waaruit ook al bleek dat Remdesivir nogal wat bijwerkingen had en verder weinig betekende voor covidbehandeling. Maar zo'n hoog sterftepercentage had ik nog niet gelezen. https://t.co/f3Np9WHI5c
7-19-2022: Bryan, Texas: For remdesivir, trust only the studies that were done outside of Gilead's bribe money: https://t.co/3OF64vX5rK https://t.co/On6Ro0CvLT https://t.co/IUyTSfzOgw https://t.co/HuGuxuhpnn https://t.co/Nier1CHjoC https://t.co/VBwC3LMyfU
@babouviste @VIsfGSyHb3DyGmM @ARenee1971 @PeterSweden7 Really that’s odd because here is the Lancet publishing a paper on Remdesivir efficacy in treating covid which finds that patients don’t benefit from it. https://t.co/P43Gl9xKBk
By that time, in May 16th China had said it was garbage ... "In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was not associated with statistically significant clinical benefits" But we believe China when it suits us
@BigJohnnyCigar @TheoFleury14 No, Remdesivir is not a successful treatment. Multiple studies showed no difference in patients, and it comes with deadly side effects due to its toxicity. Also, it failed Ebola trial - it killed more people than it helped. A
RT @7thclouds: @Trikerider704 英米いずれでも #レムデシベル の副作用に肺機能障害等深刻な副作用の報告はないが英国ランチェットは「#新型コロナウイルス への効果の有意性疑問 https://t.co/snJXIXA83p」「米国FDAはレムデシビル…
RT @7thclouds: 重症予防・死亡予防にオミクロンにも有効 ファイザー製薬飲み薬 #パキロビット 点滴薬 #ソトロビマブ 早急に処方を 国際的に効果疑問視レムデシベルとモラヌピレビルを日本の医師がコロナ治療効果で有意性認められないにもかかわらず3割がコロナに無効なレム…
@AJLoebel @Craftmastah @elonmusk @MartinKulldorff @DrJBhattacharya Remdesivir worked great for most people without ANY kidney damage https://t.co/MHzBrEFqbo
Finally not censored!
RT @7thclouds: 重症予防・死亡予防にオミクロンにも有効 ファイザー製薬飲み薬 #パキロビット 点滴薬 #ソトロビマブ 早急に処方を 国際的に効果疑問視レムデシベルとモラヌピレビルを日本の医師がコロナ治療効果で有意性認められないにもかかわらず3割がコロナに無効なレム…
@rieske_piotr @StabrawaL Proszę mi nie zarzucać manipulacji Panie Profesorze a skupić się na faktach. Remdesivir nie ma wpływu na pacjentów hospit. z covid. Nie piszemy o jego potencjale w 1. dobie infekcji, bo jak obaj wiemy, wtedy pacjent jeszcze nawet n
@m17au @Bupolo_ @_Prometeusz_ Problem is that SAE are show stopper (but ignored) so overall mortality is NEGATIVE https://t.co/gYYIenHN1w
@RhondaPeytonRN @MillisCasey @AndyMCollings @DrAseemMalhotra "Adverse events were reported in 66% of 155 remdesivir recipients versus 64% of 78 placebo recipients" https://t.co/b6I6aVsp7c
@alexandrosM Did you mention higher mortality in key study? https://t.co/gYYIenHN1w
@bhansenmd @AngelaKwan4 @woodsmasher @AprilMarie710 https://t.co/KYhOL2xRii Any other studies on remdesivir. The findings are not significant, less than 300 people in control groups. Remdesivir has lots of drug interactions yet widely used and deemed effec
RT @zegaracr: @NestorG99 @ydeigin Check study, where they ignore negative mortality (8% higher rel. death inc. in remdesivir group) https:/…
RT @zegaracr: @NestorG99 @ydeigin Check study, where they ignore negative mortality (8% higher rel. death inc. in remdesivir group) https:/…
RT @zegaracr: @NestorG99 @ydeigin Check study, where they ignore negative mortality (8% higher rel. death inc. in remdesivir group) https:/…
RT @zegaracr: @F125AXer @Patriot0731 @SteveDeaceShow Yeah when you go from ~+70% to -8%... https://t.co/gYYIenHN1w
RT @zegaracr: @F125AXer @Patriot0731 @SteveDeaceShow Yeah when you go from ~+70% to -8%... https://t.co/gYYIenHN1w
@F125AXer @Patriot0731 @SteveDeaceShow Yeah when you go from ~+70% to -8%... https://t.co/gYYIenHN1w
@SAY590 @charlesadler You write certainly about uncertainties. What we do know: it doesn’t produce positive results for patients. So at best, with what we can be certain about, he was wrong and hasn’t made any effort to correct that. https://t.co/juZj4RPFM
RT @keisuke4713: レムデシビルは入院期間を延長する 2020年2月6日から2020年3月12日まで中国10病院で無作為化二重盲検プラセボ対照試験 https://t.co/JyVXHpjCrQ レムデシビルが統計的有意効果なく、重篤な有害事象を起こした→早期中…
@NestorG99 @ydeigin Check study, where they ignore negative mortality (8% higher rel. death inc. in remdesivir group) https://t.co/6r7jT5HHcs and "focus" on faster time to recovery (EUA was granted on those grounds)... That tells me that these "scientists"
Los deberían denunciar ante tribunales. https://t.co/KcLFCqdckI
Remdesivir: not effective https://t.co/mPb2hxApHl https://t.co/YGuxA5FIW1
@radicbozo81 Moze izracun "redukcije" mortaliteta za studiju koja je remdesiviru omogucila EUA https://t.co/6r7jT5HHcs
@LeVrai_Batman @JeanYvesCAPO @marseille_jeff la preuve par la publi,... celui la aussi est publié, mais bon l'effet est discutable. https://t.co/1zF2HxUNbS
RT @keisuke4713: レムデシビルは入院期間を延長する 2020年2月6日から2020年3月12日まで中国10病院で無作為化二重盲検プラセボ対照試験 https://t.co/JyVXHpjCrQ レムデシビルが統計的有意効果なく、重篤な有害事象を起こした→早期中…
RT @keisuke4713: レムデシビルは入院期間を延長する 2020年2月6日から2020年3月12日まで中国10病院で無作為化二重盲検プラセボ対照試験 https://t.co/JyVXHpjCrQ レムデシビルが統計的有意効果なく、重篤な有害事象を起こした→早期中…
RT @keisuke4713: レムデシビルは入院期間を延長する 2020年2月6日から2020年3月12日まで中国10病院で無作為化二重盲検プラセボ対照試験 https://t.co/JyVXHpjCrQ レムデシビルが統計的有意効果なく、重篤な有害事象を起こした→早期中…
@T_Fiolet je suppose que celui là est meilleur? https://t.co/Oxsm9TnWzl
REFERENCES: 1. https://t.co/LO4ptPeoFt 2. https://t.co/vN6kAmYVCu 3. https://t.co/wVApwyXcw1 4. https://t.co/9j4rf3TQTi 5. https://t.co/CJwKqj6RQT 6. https://t.co/mTDat7DmNW 7. https://t.co/epuND0FDKm (Image adopted from this publication) 8. https:
@S0H3AVY @MullingMueller @medriva Monoclonal antibodies only work for the Wuhan virus which is long gone. Remdesivir, a failed Ebola drug routinely causes severe organ damage and often, death. https://t.co/JNLShcHWsX
@mamen_woman ¿Qué te parece? https://t.co/agw2v2fmgk
In questo studio su pazienti adulti ricoverati in ospedale per covid-19 grave il remdesevir non è stato associato a benefici clinici significativi. https://t.co/AueWmmb5ob
Of course, there weren't benefits. Doctors I've heard don't call it the killer for nothing.
@JamesLynchGTC @HealthySaneBE @matt_quantum @cappuccino64 Remdesivir kills people; https://t.co/oRUGOSNiqG, https://t.co/STOn1i6dQv, not clinically beneficial;https://t.co/ohmF4IIzdX "remdesivir was not associated with statistically significant clinical be
RT @StevePhillipsMD: Remdesivir study authors: "In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was no…
RT @StevePhillipsMD: Remdesivir study authors: "In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was no…
RT @StevePhillipsMD: Remdesivir study authors: "In this study of adult patients admitted to hospital for severe COVID-19, remdesivir was no…
RT @johndmtb: @KLVeritas Is this the same Remdesivir reported in the Lancet? The one showing no improvement over the placebo. The one where…
RT @johndmtb: @KLVeritas Is this the same Remdesivir reported in the Lancet? The one showing no improvement over the placebo. The one where…
@KLVeritas Is this the same Remdesivir reported in the Lancet? The one showing no improvement over the placebo. The one where treatment was stopped due to adverse side effects? https://t.co/kt2X5vrMMW
RT @7thclouds: ファイザー製薬抗ウイルス薬飲み薬 #パクスロビド #パキロビッドパック コロナ活動抑制し深刻な細胞破壊とそれにより引き起こされる自己免疫過剰による細胞破壊を予防 だが医師が処方控えの傾向は問題厚生労働省資料https://t.co/hvEPpb1n…
@JapanCenturion あれ? レムデシビルは、二重盲検結果で承認されてましたか? https://t.co/mcG7VZSt53 https://t.co/28BfNPuEbZ
RT @shri_v: @PradipDoshi4 @DawnsMission Wrong question. I could have given proof if the govt had collected data. Specially when studies su…
@PradipDoshi4 @DawnsMission Wrong question. I could have given proof if the govt had collected data. Specially when studies suggested this 👇🏾 https://t.co/vO8dGll3w0 https://t.co/617igt4yHH
RT @7thclouds: 重症予防・死亡予防にオミクロンにも有効 ファイザー製薬飲み薬 #パキロビット 点滴薬 #ソトロビマブ 早急に処方を 国際的に効果疑問視レムデシベルとモラヌピレビルを日本の医師がコロナ治療効果で有意性認められないにもかかわらず3割がコロナに無効なレム…
RT @7thclouds: ファイザー製薬抗ウイルス薬飲み薬 #パクスロビド #パキロビッドパック コロナ活動抑制し深刻な細胞破壊とそれにより引き起こされる自己免疫過剰による細胞破壊を予防 だが医師が処方控えの傾向は問題厚生労働省資料https://t.co/hvEPpb1n…
RT @7thclouds: ファイザー製薬抗ウイルス薬飲み薬 #パクスロビド #パキロビッドパック コロナ活動抑制し深刻な細胞破壊とそれにより引き起こされる自己免疫過剰による細胞破壊を予防 だが医師が処方控えの傾向は問題厚生労働省資料https://t.co/hvEPpb1n…
RT @7thclouds: @Trikerider704 英米いずれでも #レムデシベル の副作用に肺機能障害等深刻な副作用の報告はないが英国ランチェットは「#新型コロナウイルス への効果の有意性疑問 https://t.co/snJXIXA83p」「米国FDAはレムデシビル…
RT @7thclouds: #レムデシベル 英国治験結果。問題は「新型肺炎への治療効果有意性ない」点 2割に副作用低アルブミン。本研究で肺炎悪化の #副作用 なかった>“Remdesivir in adults with severe COVID-19: a randomis…
RT @7thclouds: レムデシベルは新型コロナには有意性なく効かない
@it_all_about_mi @megynkelly Sources like; https://t.co/s3anX3Z2N1 https://t.co/cUQw7ECJgk https://t.co/kqrajUeYIi I and my husband are recently retired healthcare providers. Do you even know how remdesivir works? And what are YOUR sources? The demon se
ファイザー製薬抗ウイルス薬飲み薬 #パクスロビド #パキロビッドパック コロナ活動抑制し深刻な細胞破壊とそれにより引き起こされる自己免疫過剰による細胞破壊を予防 だが医師が処方控えの傾向は問題厚生労働省資料https://t.co/hvEPpb1nl4を自分で調べ大丈夫ならお薬手帳示し医師に処方してもらおう https://t.co/k1gDwXvYVP
ファイザー製薬抗ウイルス薬飲み薬 #パクスロビド #パキロビッドパック コロナ活動抑制し深刻な細胞破壊とそれにより引き起こされる自己免疫過剰による細胞破壊を予防 だが医師が処方控えの傾向は問題厚生労働省資料https://t.co/hvEPpb1nl4を自分で調べ大丈夫ならお薬手帳示し医師に処方してもらおう https://t.co/CeHTnbgDqB
レムデシベルは新型コロナには有意性なく効かない
@wello_yello @MarkHan31968535 @beverleyturner @abiroberts @RobertKennedyJr I will give you a little helping start. Enjoy a bit of real science.... https://t.co/WLoGtaNNHs
11-9-2021: In a new study from Fort Belvoir, Virginia, remdesivir had zero efficacy against COVID-19, even when dexamethasone was added https://t.co/j5Kp3AHr6o https://t.co/Hn9LG9eWgD https://t.co/IUyTSfhF2o https://t.co/oYKcGjhlZv https://t.co/cP1U7MqmPW
@OkochasKrampon @acun_karadag (ilk RKÇ (Randomize Kontrollü Çalışma) : Remdesivir vs Placebo). Covid-19 tanılı ciddi hastalar alınmış. İlaç grubunda anlamlı klinik fayda tespit edilmemiş. Çalışma çeşitli sebeplerden ötürü erken sonlandırılmış. https:/
2-19-22: Boston, MA: Remdesivir just drains the U.S. Treasury: https://t.co/Sho13HMstT https://t.co/wIFy98sC8j https://t.co/CJboojYXcR https://t.co/IUyTSfzOgw https://t.co/X6l0EH1T6n https://t.co/f3He7VcP1F https://t.co/9HLa7FleVV https://t.co/ufaTgPaHJm
RT @Foxydoordecor: @alexandrosM Remdesivir showed very limited efficacy from the get go, but yet they approved it, and used it anyways. I…
@alexandrosM Remdesivir showed very limited efficacy from the get go, but yet they approved it, and used it anyways. I lost 2 family members who were treated with Remdisivir. Both died within 36 hours after. https://t.co/JK1az3tiSV https://t.co/OVGOyLF
@msdh cms also gives the hospital 20% bonus to give it. How much does Dobbs get?
RT @sohnglass: 랜셋 (Lancet) 논문에서 밝혀진 렘데시비르의 맹독성. 이는 FDA 승인 꿈을 산산조각내기에 충분했던 부정적 결과 #렘데시비르 는 환자를 살리지도 못했고 입원기간을 줄이지도 못했으며 혈중 바이러스를 줄이지도 못함.…
RT @sohnglass: 랜셋 (Lancet) 논문에서 밝혀진 렘데시비르의 맹독성. 이는 FDA 승인 꿈을 산산조각내기에 충분했던 부정적 결과 #렘데시비르 는 환자를 살리지도 못했고 입원기간을 줄이지도 못했으며 혈중 바이러스를 줄이지도 못함.…
@normanswan I have been sent these references to suggest covid vaccinations do result in increased heart disease and strokes. Norman could you make this a priority on coronacast and reply: https://t.co/2I4sMva2Wy https://t.co/ru9UTn6Uun https://t.co/EVy
랜셋 (Lancet) 논문에서 밝혀진 렘데시비르의 맹독성. 이는 FDA 승인 꿈을 산산조각내기에 충분했던 부정적 결과 #렘데시비르 는 환자를 살리지도 못했고 입원기간을 줄이지도 못했으며 혈중 바이러스를 줄이지도 못함. 6/n https://t.co/P5SSbJUGQs
RT @8simon9: @ScottAdamsSays In January 2020 China ran studies on Remdesivir which showed no to little benefit. Too many adverse reactions…
@ScottAdamsSays In January 2020 China ran studies on Remdesivir which showed no to little benefit. Too many adverse reactions https://t.co/a8WwqfciUU https://t.co/YLyhoIkOfE
The smaller double-blind placebo-controlled RCT was sponsored by Capital Medical University in China and showed no statistically-significant mortality reduction or hospitalization time reduction with RDV 3/10 https://t.co/g6xPAJoNth
@RealCalvin1 "...remdesivir was not associated with statistically significant clinical benefits..." https://t.co/pPvDdGooVr
@JamesLynchGTC @Annakhait [It doesnt.] https://t.co/FFNe6twtGh Read the findings again.
@L1011D @Annakhait A Gilead study in China? Reference your statements. Gilead are the company. I can find three studies that meet your description. None demonstrate a mortality increase. https://t.co/6VpPNvhngu https://t.co/zbXAxQVP8E https://t.co/dAPagLw
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial - PubMed https://t.co/jiNig6OxFz
@megtirrell @Muller_Lab Its a toxic treatment thats not effective and even the WHO recommends against its use. https://t.co/t4Dt2laoEc https://t.co/ya4j6RKZRG
12-27-21: In India, the Centre warned against early remdesivir: https://t.co/ufaTgOSyve https://t.co/9HLa7F35HN https://t.co/IUyTSfhF2o https://t.co/j5Kp3AHr6o https://t.co/CJbookg0eR https://t.co/wIFy98asUb https://t.co/Sho13I3vvT https://t.co/0sp3sNWsEi
@DweblinVeltz @NovichokRossiya @OhFuckItsRayner Ineffective and toxicity of Remdesivir Let me know of you want more studies that point to the toxicity of Remdesivir https://t.co/aooOFinIu0